Solventum Corporation
SOLV
$70.40
-$0.41-0.58%
NYSE
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 2.00B | 2.10B | 2.16B | 2.07B | 2.08B |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 2.00B | 2.10B | 2.16B | 2.07B | 2.08B |
| Cost of Revenue | 972.00M | 963.00M | 985.00M | 946.00M | 937.00M |
| Gross Profit | 1.03B | 1.13B | 1.18B | 1.12B | 1.14B |
| SG&A Expenses | 763.00M | 786.00M | 777.00M | 774.00M | 746.00M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 1.91B | 1.93B | 1.95B | 1.91B | 1.88B |
| Operating Income | 88.00M | 164.00M | 212.00M | 160.00M | 200.00M |
| Income Before Tax | 58.00M | 1.51B | 103.00M | 38.00M | 14.00M |
| Income Tax Expenses | -5.00M | 248.00M | 13.00M | -99.00M | -17.00M |
| Earnings from Continuing Operations | 63.00M | 1.27B | 90.00M | 137.00M | 31.00M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 63.00M | 1.27B | 90.00M | 137.00M | 31.00M |
| EBIT | 88.00M | 164.00M | 212.00M | 160.00M | 200.00M |
| EBITDA | 205.00M | 285.00M | 334.00M | 289.00M | 350.00M |
| EPS Basic | 0.36 | 7.26 | 0.52 | 0.79 | 0.18 |
| Normalized Basic EPS | 0.12 | 0.29 | 0.40 | 0.20 | 0.27 |
| EPS Diluted | 0.36 | 7.22 | 0.51 | 0.78 | 0.18 |
| Normalized Diluted EPS | 0.12 | 0.29 | 0.40 | 0.20 | 0.27 |
| Average Basic Shares Outstanding | 174.40M | 174.30M | 174.10M | 173.70M | 173.40M |
| Average Diluted Shares Outstanding | 175.70M | 175.40M | 175.20M | 174.80M | 174.50M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |